课题基金 / 基金详情

13th Hershey Developmental Brain Injury Conference

13th Hershey Developmental Brain Injury Conference
第十三届好时发育性脑损伤会议
批准号:
10467344
负责人:
Sandra E Juul
金额:
$2.5万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2022
资助国家:
美国
项目状态:
已结题
起止时间:
2022-03-01 至 2023-02-28

项目摘要

项目成果

Sandra E Juul的其他基金

相似基金

相关文献

中文摘要
翻译
项目概要/摘要 好时发展性脑损伤会议始于1997年,现已发展成为一个高质量的会议。 该计划吸引了国际与会者,包括医生科学家,基础科学家和学员。 会议每隔一年举行一次,地点在国际和美国地点之间交替。 会议包括受邀发言人谁是在该领域的杰出人物,以及会议中,更多的初级 研究人员分享他们的工作。本次会议为学员和年轻人提供了一个惊人的机会, 调查员在轻松的环境中与外地的高级调查员会面和互动。科学 介绍总是很出色。2022年第13届好时会议由桑德拉·尤尔博士组织, 伊丽莎白·南斯和托马斯·伍德将在太平洋西北部西雅图华盛顿外的 奥尔德布鲁克温泉度假村我们正在向国家卫生研究院申请支持,主要是为了资助青少年的出勤 调查员和学员。拟议会议的总体目标是召集一个国际小组, 专注于新生儿脑损伤和修复的科学家。今年的主题是:影响 环境对发育性脑损伤的患病率和结果的影响。这次为期三天的会议 将包括以下会议:发育性脑损伤的长期后果;脑老化和 对二次打击事件的易感性;表观遗传和微生物组效应;机制和细胞成像, 对早产儿/LBW的社会、环境和全身影响。会议有四个目标: 1)确定告知基本科学概念的临床范例,并翻译这些新的基本概念 更精细的临床应用 2)探索我们现有知识中的空白领域,并邀请边缘领域的专家提供 对这些差距的新看法 3)促进新的合作 4)促进学员和初级教师的参与,并从种族/民族中识别学员/初级教师 少数群体和代表性不足的机构参加这次会议并发展新的合作。在 总而言之,R13的目标是为学员和初级 第13届Hershey脑损伤发展会议广泛参与 来自美国和国外的培训生一直是好时会议的标志。学员,均为医学博士 博士占所有参与者的30-40%。本次会议提供了一个非正式的机会, 学员与该领域领导人之间的互动,以及博士后和 招募访问科学家
英文摘要
PROJECT SUMMARY/ABSTRACT The Hershey Conference on Developmental Brain Injury was started in 1997 and has grown to a high-quality program that attracts international attendees that include physician-scientists, basic scientists, and trainees. The conference is held every other year, and the site alternates between international and US locations. Sessions include invited speakers who are luminaries in the field, as well as sessions in which more junior investigators share their work. This conference offers an amazing opportunity for trainees and young investigators to meet and interact with senior investigators in the field in a relaxed environment. The scientific presentations are always outstanding. The 2022 13th Hershey Conference organized by Drs. Sandra Juul, Elizabeth Nance and Thomas Wood will be held in the Pacific Northwest, outside of Seattle Washington at the Alderbrook Resort and Spa. We are applying to NIH for support primarily to fund attendance for junior investigators and trainees. The overall goal of the proposed meeting is to bring together an international group of scientists whose focus is on neonatal brain injury and repair. This year’s overarching theme will be: Effects of the environment on prevalence and outcomes of developmental brain injury. This three-day meeting will include the following sessions: Long-term consequences of developmental brain injury; Brain aging and susceptibility to second hit events; Epigenetic and microbiome effects; Mechanisms and cellular imaging and Societal; environmental, and systemic effects on premature/LBW. The meeting has four objectives: 1) To identify clinical paradigms that inform basic science concepts and translate those new basic concepts into more refined clinical application 2) To explore areas of gaps in our current knowledge, and to include experts in tangential fields to provide new perspectives on these gaps 3) To promote novel collaborations 4) To promote trainee and junior faculty participation and to identify trainees/junior faculty from racial/ethnic minorities and underrepresented institutions to attend this conference and develop new collaborations. In summary, the objective of this R13 is to provide the necessary continued support for trainees and junior faculty to attend the 13th Hershey Conference on Developmental Brain Injury. Extensive participation of trainees, both from US and abroad, has been a hallmark of the Hershey Conference. Trainees, both MD and PhD, constitute 30-40% of all participants. This meeting provides an excellent opportunity for informal interaction between trainees and the leaders in the field as well as a mechanism for post-doctoral and visiting scientist recruitment.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Trial of Darbepoetin plus slow-release intravenous iron to decrease transfusions and improve iron status and neurodevelopment in preterm infants
  • 批准号:
    10662182
  • 项目类别:
  • 资助金额:
    $56.38万
  • 财政年份:
    2022
  • 负责人:
    Sandra E Juul
  • 依托单位:
Trial of Darbepoetin plus slow-release intravenous iron to decrease transfusions and improve iron status and neurodevelopment in preterm infants
  • 批准号:
    10340574
  • 项目类别:
  • 资助金额:
    $49.23万
  • 财政年份:
    2022
  • 负责人:
    Sandra E Juul
  • 依托单位:
Intellectual and Developmental Disabilities Research Center
  • 批准号:
    10661668
  • 项目类别:
  • 资助金额:
    $127.18万
  • 财政年份:
    2020
  • 负责人:
    Sandra E Juul
  • 依托单位:
High-dose Erythropoietin for Asphyxia and Encephalopathy (HEAL) CCC
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: